However, in LB cancers, it was negatively correlated with tumor size (Tau-c = −0.465; p = 0.005) and disease stage (Tau-c = −0.382; p = 0.04), and in HER2-enriched BCs it negatively correlated with the presence of LNM (Tau-b = −0.559; p = 0.015) and with disease stage (Tau-c = −0.639; p = 0.001) (Table 3). Here, ERBB2 is linked to neoplasm.